Searchable abstracts of presentations at key conferences in endocrinology

ea0044p30 | Adrenal and Steroids | SFEBES2016

Suppression of 11β-hydroxysteroid dehydrogenase type 1 target gene regulation by hypoxia

Shammout Bushra , Alase Adewonuola , Wittmann Miriam , Stewart Paul , Tiganescu Ana

Delayed wound healing (WH), characterized by ischemia, is exacerbated by glucocorticoid (GC) excess. Local GC availability is regulated by the enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) which generates the GC cortisol from inactive cortisone. We previously reported improved WH in 11β-HSD1-null mice but regulation of 11β-HSD1 by hypoxia in human skin remains unknown. Primary human dermal fibroblasts (HDF, biological n=3), were treated...

ea0038oc3.3 | Steroids and adrenal | SFEBES2015

11β-HSD1-mediated decrease in COX2 expression is abrogated by hypoxia in human dermal fibroblasts

Tiganescu Ana , Wittmann Miriam , Morgan Ann , Stewart Paul

Chronic wounds contribute significantly to patient morbidity, mortality and associated healthcare costs. Glucocorticoid (GC) excess and hypoxia are both associated with impaired wound healing (WH) outcomes. The cyclooxygerase 2 (COX2) pathway is an integral component of inflammation and WH. Locally, GC availability is regulated by the enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) which generates cortisol from inactive cortisone. Although we recently demon...

ea0084ps3-15-137 | Thyroid Cancer Diagnosis & Treatment | ETA2022

Tendency of progression of antithyroglobulin antibody as a predictor of prognosis in patients with papillary thyroid carcinoma

Carvalho Dias Pinto Camila , Vera Montali da Assumpcao Ligia , Zantut Wittmann Denise Engelbrecht

Objectives: The clinical significance of antithyroglobulin antibody (TgAb) levels verified concomitantly with undetectable thyroglobulin (Tg) during the follow-up of patients with differentiated thyroid carcinoma remains under debate. The present study aimed to evaluate the presence and prognostic predictive value of TgAb during the follow-up of patients with differentiated thyroid carcinoma.Methods: A retrospective cohort study was performed by reviewin...

ea0041gp162 | Pituitary - Clinical (1) | ECE2016

Hippocampal and cerebellar atrophy in patients with Cushings disease

Burkhardt Till , Ludecke Daniel , Spies Lothar , Linus Wittmann , Westphal Manfred , Flitsch Jorg

Objective: Cushing’s disease (CD) may cause atrophy of different regions of the human brain, mostly affecting the hippocampus and the cerebellum. This study evaluates the use of 3-T MRI of newly diagnosed patients with CD to detect atrophic degeneration with voxel-based volumetry.Methods: Subjects with newly diagnosed, untreated CD were included and underwent 3-T MRI. Images were analyzed using a voxelwise statistical test to detect reduction of bra...

ea0029p1835 | Thyroid cancer | ICEECE2012

Appearance of secondary primary malignancies in patients with differentiated tumours of the thyroid gland

Sepp K. , Valkusz Z. , Nagy M. , Csajbok C. , Magony S. , Julesz J. , Wittmann T.

Introduction: thyroid carcinoma is an uncommon malignancy, but it’s incidence appears to be increasing slowly (female 2–3.8/100.000 - male 1.2–2.6/100.000). This is the most common malignant endocrine tumour, represents about 1% of all malignancies. The majority of these patients females, mostly between the age of 30–60. The main differentiated histological types are papillary and follicular. The options of the treatment are surgical removal (mainly total),...

ea0092ps1-03-05 | Miscellaneous 1 | ETA2023

Thyroid dysfunction in head and neck squamous cell carcinoma patients after external radiotherapy: clinicopathological risk factors

Russo Fiore Adriana , Silvia Lima Carmen , Pereira Eduardo , Engelbrecht Zantut Wittmann Denise

Background: Radiotherapy (RT) with or without chemotherapy is a common treatment for head and neck squamous cell carcinoma (HNSCC) patients and it can cause adverse effects, including dysfunctions of thyroid. The aim of this study was to identify thyroid dysfunction among patients submitted to external RT for treatment of HNSCC, with serial evaluation of thyroid function.Material and methods: This is a retrospective longitudinal study of the follow-up of...

ea0092ps3-24-06 | Thyroid Eye Disease | ETA2023

Perceptions reported by graves’ disease euthyroid patients with ophthalmopathy: A qualitative study

Cesar Reis Juliano , Valladao Lucas , Casagrande Carla , Engelbrecht Zantut Wittmann Denise , Turato Egberto

Introduction: Knowing mental representations about the phenomenon of illness and medical care allows the clinical team to have better emotional handling of their patients, with gains in greater adherence to treatments. Graves’ Ophthalmopathy is an inflammatory disease with primary involvement of the extraocular muscles and orbit, being the most frequent extrathyroidal manifestation of Graves’ disease (GD). Many patients have psychological status changes even after su...

ea0029p384 | Clinical case reports - Pituitary/Adrenal | ICEECE2012

A case history as example for diagnostics and treatment of acromegaly: started and ended with pregnancy

Magony S. , Valkusz Z. , Csajbok Z. , Sepp K. , Gardi J. , Szecsi M. , Kiss I. , Wittmann T. , Julesz J.

The history of a female patient is demonstrated as an example of diagnostic and therapeutical pitfalls in acromegaly. The patient was first operated on a pituitary macroadenoma at her age of 21. Prior to surgery, serum prolactin was found moderately elevated and the patient was raromenorrhoic, without galactorrhea. Soon recurrence of the tumour was trialed with bromocriptine medication, however, without any inhibitory effect on the process. The patient underwent a second neuro...

ea0014p563 | (1) | ECE2007

Distribution of type 1 cannabinoid receptor (CB1) immunoreactive axons in the mouse hypothalamus

Wittmann Gábor , Deli Levente , Kalló Imre , Hrabovszky Erik , Watanabe Masahiko , Liposits Zsolt , Fekete Csaba

Type 1 cannabinoid receptor (CB1) is the principal receptor for endocannabinoids in the brain which mainly occurs in preterminal/terminal axons and mediates retrograde neuronal signaling mechanisms. A large body of physiological and electrophysiological evidence indicates the critical role of CB1 in the regulation of hypothalamic functions. Conversely, the distribution of CB1-containing axons in the hypothalamus is essentially unknown. Therefore, we have analyzed the distribut...

ea0013p291 | Steroids | SFEBES2007

The effects of glucocorticoids on the expression of gluconeogenic and lipogenic enzymes in a rodent model of Cushing’s Syndrome

Lolli Francesca , Christ-Crain Mirjam , Kola Blerina , Fekete Csaba , Wittman Gabor , Grossman Ashley B. , Korbonits Marta

Background: Cushing’s syndrome results from chronic exposure to excessive levels of glucocorticoids (GC). The clinical manifestations associated with hypercortisolaemia are variable and differ widely in severity, including hypertension, apparent obesity and metabolic aberrations such as diabetes, dyslipidaemia, ultimately leading to changes similar to the metabolic syndrome. We hypothesised that GC might influence the expression of the genes involved in lipogenesis and gl...